Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Survival Curves01:18

Survival Curves

Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Pharmacodynamic Models: Logarithmic Concentration–Effect Model01:15

Pharmacodynamic Models: Logarithmic Concentration–Effect Model

The log-linear model is a pharmacological framework used to describe the relationship between drug concentration and its effect. This model is particularly relevant when the observed effects range between 20% and 80% of the drug’s maximum effect (Emax), where a near-linear relationship is observed between the log of drug concentration and the measured effect. However, the log-linear model does not predict the maximum possible effect (Emax) or the effect at zero drug concentration, limiting its...
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Distributions to Estimate Population Parameter01:26

Distributions to Estimate Population Parameter

The accurate values of population parameters such as population proportion, population mean, and population standard deviation (or variance) are usually unknown. These are fixed values that can only be estimated from the data collected from the samples. The estimates of each of these parameters are sample proportion, the sample mean, and sample standard deviation (or variance). To obtain the values of these sample statistics, data are required that have particular distribution and central...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Spatiotemporal Analysis of Hemodialysis Incidence Rate and Impact of the COVID-19 Pandemic on the End-Stage Kidney Disease Trend.

Iranian journal of kidney diseases·2026
Same author

Evaluation of the Performance of Biomarkers in Predicting Hemodialysis Patients Survival Using Time-Dependent ROC Curve.

Iranian journal of kidney diseases·2026
Same author

An evaluation of variable selection methods in competing risks with one rare event: a simulation study.

BMC medical research methodology·2026
Same author

Cancer Unveiling: A Profile of Incidence and Trends in Bam City, Southeast Iran.

South Asian journal of cancer·2025
Same author

Measurement of COVID-19 vaccination acceptance and associated factors among Afghan refugees in Iran: insights from a cross-sectional study.

BMC public health·2025
Same author

Macular Sublayer Thickness in Healthy Iranian Children: An Optical Coherence Tomography Study from the Population-Based Shiraz Pediatric Eye Study.

Journal of current ophthalmology·2025

Related Experiment Video

Updated: May 27, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

A parametric method for cumulative incidence modeling with a new four-parameter log-logistic distribution.

Zahra Shayan1, Seyyed Mohammad Taghi Ayatollahi, Najaf Zare

  • 1Department of Biostatistics, Shiraz University of Medical Sciences, Shiraz, Iran.

Theoretical Biology & Medical Modelling
|November 15, 2011
PubMed
Summary

This study introduces a new parametric distribution for analyzing competing risks data, improving cumulative incidence function estimation accuracy compared to non-parametric methods in simulations and real-world applications.

More Related Videos

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Related Experiment Videos

Last Updated: May 27, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

Area of Science:

  • Biostatistics
  • Survival Analysis
  • Epidemiology

Background:

  • Competing risks are crucial in medical studies, necessitating appropriate analytical methods.
  • Cumulative incidence functions are commonly modeled using non- or semi-parametric approaches.
  • Parametric models offer enhanced efficiency and flexibility for various hazard function shapes.

Purpose of the Study:

  • To propose a novel four-parameter parametric distribution for modeling cumulative incidence functions in competing risks.
  • To evaluate the performance of the new distribution against non-parametric methods via simulation.
  • To demonstrate the practical utility of the proposed distribution using real-world fertility data.

Main Methods:

  • Extension of a two-parameter log-logistic distribution using Hougaard's stable distributions family.
  • Simulation study comparing the proposed parametric model with a non-parametric method for cumulative incidence estimation.
  • Application of the new model to historical fertility data.

Main Results:

  • Simulation results indicated superior accuracy of the proposed parametric cumulative incidence function estimates in certain scenarios.
  • The new distribution demonstrated a significantly better fit to the real fertility data compared to other tested distributions.
  • The proposed parametric model offers a robust alternative for cumulative incidence function parameterization.

Conclusions:

  • The novel four-parameter distribution provides a more accurate and better-fitting approach for cumulative incidence functions in competing risks settings.
  • The proposed parametric model is recommended for practical applications in biostatistical and epidemiological research.
  • This advancement enhances the analysis of complex event data in medical studies.